99.7% Sustained Virologic Response Rate in 369 HCV Genotype 1b‐Infected Patients Treated With Label‐Recommended Regimen of Ombitasvir/Paritaprevir/r and Dasabuvir With or Without Ribavirin: 2016. (October 2015)